Packages : Disclosure of Price Sensitive Information - Investment in Sanofi - Aventis Pakistan

Ref: Sec/90/PKGS

June 24, 2022

The General Manager

Pakistan Stock Exchange Limited

Stock Exchange Building

Stock Exchange Road

Karachi

Director/HOD

Company Law Division

Securities & Exchange Commission of Pakistan

NIC Building, Jinnah Avenue, Blue Area

Islamabad

Executive Director/HOD

Offsite-II Department, Supervision Division

Securities & Exchange Commission of Pakistan

63, NIC Building, Jinnah Avenue, Blue Area

Islamabad

Dear Sir,

Sub: Disclosure of Price Sensitive Information - Investment in Sanofi-AventisPakistan Limited (Sanofi Pakistan)

ln accordance with Sections 96 and 131 of the Securities Act, 2015 and Clause 5.6.1 of the Rule Book issued by the Pakistan Stock Exchange Limited (the "Exchange"), this is in continuation of our earlier letters SEC/169/2021 dated December 20, 2021 and SEC/56/PKGS (Annexure - C) dated April 28, 2022 on the captioned matter.

We are enclosing herewith a form disclosing intimation for extension in timeline for Public Announcement of Offer as filed today by Arif Habib Limited, the Manager to the Offer.

You are requested to disseminate the information to the Members of the Exchange accordingly.

Yours sincerely,

For Packages Limited

Iqra Sajjad

Company Secretary

Encl: Disclosure Form under SRO 143/(1)/2012 dated December 05, 2012

DISCLOSURE FORM

INTERMS OF SECTIONS 96 AND 131 OF THE SECURITIES ACT, 2015

Name of Company	Packages Limited
Date of Report	24 June 2022
Name of Company as specified in	Packages Limited
The Memorandum
Company's Registered Office	4th Floor, The Forum
	Suite # 416-422,G-20, Block 9
	Khayaban-e-Jami, Clifton
	Karachi-75600
Contact Information	Tel: [phone]

Disclosure of price sensitive / inside information by listed company in terms of Section 96 and 131:

This is in continuation of our earlier letters SEC/169/2021 dated December 20, 2021 and SEC/56/PKGS dated April 28, 2022 regarding potential acquisition of entire 52.87% shareholding of Sanofi Foreign Participants B.V. held in Sanofi-Aventis Pakistan Limited (Sanofi Pakistan) by an Investor Consortium comprising of Packages Limited, IGI Investments (Private) Limited and affiliates of Arshad Ali Gohar Group along with acquisition of such number of ordinary shares of Sanofi Pakistan as may be offered and acquired in accordance with the provisions of Part IX of the Securities Act 2015 and Listed Companies (Substantial Acquisition of Voting Shares and Takeovers) Regulations 2017. The Investor Consortium is led by Packages Limited.

In this regard, please note that Arif Habib Limited (Manager to the Offer) has made attached announcement today, on behalf of the Investor Consortium, regarding extension in timeline for Public Announcement of Offer to acquire up to 585,254 ordinary shares of Sanofi Pakistan.

Pursuant to the requirements of the Securities Act, 2015, the Company has duly caused this form/statement to be signed on its behalf by the undersigned hereunto duly authorized.

For and on behalf of

For PACKAGES LIMITED

Iqra Sajjad

Company Secretary